Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass

Diabetes

Volumn 61, Issue 8, 2012, Pages 2166-2175

  Renner, Simone ^a   Römisch Margl, Werner ^b   Prehn, Cornelia ^b   Krebs, Stefan ^a   Adamski, Jerzy ^b,c   Göke, Burkhard ^d   Blum, Helmut ^a   Suhre, Karsten ^a,b,e   Roscher, Adelbert A ^d   Wolf, Eckhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID; ARGININE; DIACYLGLYCEROL; ETHER PHOSPHOLIPID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; HISTIDINE; INCRETIN; LEUCINE; LIPID; LYSOPHOSPHATIDYLCHOLINE; ORNITHINE; PHENYLALANINE; SPHINGOMYELIN; TRANSCRIPTOME; TYROSINE; VALINE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL PIG; FEMALE; GENOTYPE; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MASS SPECTROMETRY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

AGING; AMINO ACIDS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOLOGICAL MARKERS; CARNITINE; DIGLYCERIDES; DISEASE PROGRESSION; GLUCOSE TOLERANCE TEST; INCRETINS; INSULIN; INSULIN-SECRETING CELLS; LIPIDS; LYSOPHOSPHATIDYLCHOLINES; PHOSPHOLIPID ETHERS; PREDIABETIC STATE; RECEPTORS, GASTROINTESTINAL HORMONE; SPHINGOMYELINS; SWINE; TRANSCRIPTOME;

EID: 84864300391     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1133     Document Type: Article

References (48)

1. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249-1257
2. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373:2215-2221
3. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802-1812 (Pubitemid 44033300)
4. Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 2002;51(Suppl. 1):S117-S121 (Pubitemid 34761505)
5. Renner S, Fehlings C, Herbach N, et al. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes 2010;59:1228-1238
6. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 1993;91:301-307 (Pubitemid 23037285)
7. Kosaka K, Kuzuya T, Hagura R, Yoshinaga H. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med 1996; 13(Suppl. 6):S109-S119 (Pubitemid 26316212)
8. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 2009;58:2429-2443
9. Griffiths WJ, Wang Y. Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem Soc Rev 2009;38:1882-1896
10. Koulman A, Lane GA, Harrison SJ, Volmer DA. From differentiating metabolites to biomarkers. Anal Bioanal Chem 2009;394:663-670
11. Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP. Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 2010;49: 5426-5445
12. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495 (Pubitemid 38680001)
13. Römisch-Margl W, Prehn C, Bogumil R, Röhring C, Suhre K, Adamski J. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics 2012;8:133-142.
14. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003;31:e15
15. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-15550 (Pubitemid 41528093)
16. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York, Springer, 2001
17. Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol 2004;82:506-514 (Pubitemid 39388391)
18. Pitocco D, Zaccardi F, Di Stasio E, et al. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud 2010;7:15-25
19. Romero MJ, Platt DH, Tawfik HE, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008; 102:95-102
20. Sjöholm A. Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta. FEBS Lett 1995;367:283-286
21. Kelpe CL, Moore PC, Parazzoli SD, Wicksteed B, Rhodes CJ, Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 2003;278:30015-30021 (Pubitemid 36962391)
22. Kumashiro N, Erion DM, Zhang D, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A 2011;108:16381-16385
23. Timmers S, Schrauwen P, de Vogel J. Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav 2008;94:242-251 (Pubitemid 351615425)
24. Adams SH, Hoppel CL, Lok KH, et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 2009; 139:1073-1081
25. Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004;25:455-473 (Pubitemid 39195071)
26. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273 (Pubitemid 36792858)
27. Lucio M, Fekete A, Weigert C, et al. Insulin sensitivity is reflected by characteristic metabolic fingerprints - a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS ONE 2010;5:e13317
28. Suhre K, Meisinger C, Döring A, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010;5:e13953
29. Pietiläinen KH, Sysi-Aho M, Rissanen A, et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoS ONE 2007;2:e218
30. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-326
31. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448-453
32. Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes 2002;51(Suppl. 1):S109-S116 (Pubitemid 34761504)
33. Felig P, Marliss E, Cahill GF Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969;281:811-816
34. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:193-205 (Pubitemid 351301824)
35. Pietiläinen KH, Naukkarinen J, Rissanen A, et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008;5:e51
36. Tai ES, Tan ML, Stevens RD, et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010;53:757-767
37. Gerich JE. Metabolic abnormalities in impaired glucose tolerance. Metabolism 1997;46(Suppl. 1):40-43
38. Felig P. Amino acid metabolism in man. Annu Rev Biochem 1975;44: 933-955
39. Fukagawa NK, Minaker KL, Rowe JW, et al. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Invest 1985;76:2306-2311 (Pubitemid 16155526)
40. Pruett ST, Bushnev A, Hagedorn K, et al. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J Lipid Res 2008;49:1621-1639
41. Shui G, Stebbins JW, Lam BD, et al. Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys? PLoS ONE 2011;6:e19731
42. Fox TE, Bewley MC, Unrath KA, et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res 2011;52:509-517
43. Li Z, Zhang H, Liu J, et al. Reducing plasma membrane sphingomyelin increases insulin sensitivity. Mol Cell Biol 2011;31:4205-4218
44. Yano M, Watanabe K, Yamamoto T, et al. Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice. J Biol Chem 2011;286:3992-4002
45. Engelmann B. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 2004;32:147-150 (Pubitemid 38283037)
46. Zoeller RA, Lake AC, Nagan N, Gaposchkin DP, Legner MA, Lieberthal W. Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. Biochem J 1999;338:769-776 (Pubitemid 29140085)
47. Colas R, Pruneta-Deloche V, Guichardant M, et al. Increased lipid peroxidation in LDL from type-2 diabetic patients. Lipids 2010;45:723-731
48. Marcelli-Tourvieille S, Hubert T, Pattou F, Vantyghem MC. Acute insulin response (AIR): review of protocols and clinical interest in islet transplantation. Diabetes Metab 2006;32:295-303 (Pubitemid 44410142)